| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 1 | 2,000 | ₹1,02,000 |
| HNI / NII | 2 | 4,000 | ₹2,04,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII / HNI (Total) | — | 5,78,000 (47.38%) | — | ₹294.78 Cr |
| Retail Investors | — | 5,80,000 (47.54%) | — | ₹295.80 Cr |
| Total ** | — | 12,20,000 (100.00%) | — | ₹6,222.00 Cr |
| Market Maker * | — | 62,000 (5.08%) | — | ₹3.16 Cr |
| Metric | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 436.42 | 650.13 | 558.49 |
| PAT | 34.08 | 50.07 | 35.90 |
| EBITDA | — | — | — |
| Net Worth | 370.78 | 337.42 | 136.30 |
| Total Assets | 644.00 | 514.77 | 395.87 |
| Reserves | 57.18 | 141.42 | -13.70 |
| Borrowings | 138.31 | 104.52 | 173.77 |
Incorporated in 2007, Hamps Bio Limited is engaged in the marketing and distribution of pharmaceutical products like tablets, syrups, capsules, injectables, oil, and nutritional supplements.
The company distributes its products through a network of over 50 distributors and e-commerce platforms, including Amazon (US, Canada, EU), Flipkart, and Jio Mart. Their pharma products are sold in 8 states and union territories, while Freeze-dried and Frozen products reach 6 countries and 22 states and union territories.
The company's business is divided into two segments:
The company offers over 180 products across both segments. As of October 31, 2024, The company had 78 employees.
Competitive Strengths: